PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE
A controlled release pharmaceutical composition containing (1) (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)ammino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, (2) one or more additives for having water seep into the inside of the preparation, said add...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; hun |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MURAYAMA, Emiko TAKAISHI, Yuuki NISHIZATO, Takashi SAKO, Kazuhiro MURAYAMA, Daisuke TAKAHASHI, Yutaka NAKAMURA, Soichiro |
| description | A controlled release pharmaceutical composition containing (1) (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)ammino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, (2) one or more additives for having water seep into the inside of the preparation, said additives having such a solubility that the amount of water required for dissolving 1g of the additives is not more than 10 mL, and (3) a polymer material for forming a hydrogel, said polymer material having an average molecular weight of about 100,000 or more and a viscosity of not less than 12 mPa·s as measured in the form of a 5% aqueous solution at 25°C. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HUE052874TT2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HUE052874TT2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HUE052874TT23</originalsourceid><addsrcrecordid>eNrjZNAP8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Nw8w9S8PV38XTzdHVRCHL1cXUMduVhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEeoa4GpkYW5iYhIUbGxKgBACXTJr4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE</title><source>esp@cenet</source><creator>MURAYAMA, Emiko ; TAKAISHI, Yuuki ; NISHIZATO, Takashi ; SAKO, Kazuhiro ; MURAYAMA, Daisuke ; TAKAHASHI, Yutaka ; NAKAMURA, Soichiro</creator><creatorcontrib>MURAYAMA, Emiko ; TAKAISHI, Yuuki ; NISHIZATO, Takashi ; SAKO, Kazuhiro ; MURAYAMA, Daisuke ; TAKAHASHI, Yutaka ; NAKAMURA, Soichiro</creatorcontrib><description>A controlled release pharmaceutical composition containing (1) (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)ammino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, (2) one or more additives for having water seep into the inside of the preparation, said additives having such a solubility that the amount of water required for dissolving 1g of the additives is not more than 10 mL, and (3) a polymer material for forming a hydrogel, said polymer material having an average molecular weight of about 100,000 or more and a viscosity of not less than 12 mPa·s as measured in the form of a 5% aqueous solution at 25°C.</description><language>eng ; hun</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210528&DB=EPODOC&CC=HU&NR=E052874T2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210528&DB=EPODOC&CC=HU&NR=E052874T2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MURAYAMA, Emiko</creatorcontrib><creatorcontrib>TAKAISHI, Yuuki</creatorcontrib><creatorcontrib>NISHIZATO, Takashi</creatorcontrib><creatorcontrib>SAKO, Kazuhiro</creatorcontrib><creatorcontrib>MURAYAMA, Daisuke</creatorcontrib><creatorcontrib>TAKAHASHI, Yutaka</creatorcontrib><creatorcontrib>NAKAMURA, Soichiro</creatorcontrib><title>PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE</title><description>A controlled release pharmaceutical composition containing (1) (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)ammino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, (2) one or more additives for having water seep into the inside of the preparation, said additives having such a solubility that the amount of water required for dissolving 1g of the additives is not more than 10 mL, and (3) a polymer material for forming a hydrogel, said polymer material having an average molecular weight of about 100,000 or more and a viscosity of not less than 12 mPa·s as measured in the form of a 5% aqueous solution at 25°C.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAP8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Nw8w9S8PV38XTzdHVRCHL1cXUMduVhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEeoa4GpkYW5iYhIUbGxKgBACXTJr4</recordid><startdate>20210528</startdate><enddate>20210528</enddate><creator>MURAYAMA, Emiko</creator><creator>TAKAISHI, Yuuki</creator><creator>NISHIZATO, Takashi</creator><creator>SAKO, Kazuhiro</creator><creator>MURAYAMA, Daisuke</creator><creator>TAKAHASHI, Yutaka</creator><creator>NAKAMURA, Soichiro</creator><scope>EVB</scope></search><sort><creationdate>20210528</creationdate><title>PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE</title><author>MURAYAMA, Emiko ; TAKAISHI, Yuuki ; NISHIZATO, Takashi ; SAKO, Kazuhiro ; MURAYAMA, Daisuke ; TAKAHASHI, Yutaka ; NAKAMURA, Soichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HUE052874TT23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MURAYAMA, Emiko</creatorcontrib><creatorcontrib>TAKAISHI, Yuuki</creatorcontrib><creatorcontrib>NISHIZATO, Takashi</creatorcontrib><creatorcontrib>SAKO, Kazuhiro</creatorcontrib><creatorcontrib>MURAYAMA, Daisuke</creatorcontrib><creatorcontrib>TAKAHASHI, Yutaka</creatorcontrib><creatorcontrib>NAKAMURA, Soichiro</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MURAYAMA, Emiko</au><au>TAKAISHI, Yuuki</au><au>NISHIZATO, Takashi</au><au>SAKO, Kazuhiro</au><au>MURAYAMA, Daisuke</au><au>TAKAHASHI, Yutaka</au><au>NAKAMURA, Soichiro</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE</title><date>2021-05-28</date><risdate>2021</risdate><abstract>A controlled release pharmaceutical composition containing (1) (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)ammino]ethyl]acetic acid anilide or a pharmaceutically acceptable salt thereof, (2) one or more additives for having water seep into the inside of the preparation, said additives having such a solubility that the amount of water required for dissolving 1g of the additives is not more than 10 mL, and (3) a polymer material for forming a hydrogel, said polymer material having an average molecular weight of about 100,000 or more and a viscosity of not less than 12 mPa·s as measured in the form of a 5% aqueous solution at 25°C.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; hun |
| recordid | cdi_epo_espacenet_HUE052874TT2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PHARMACEUTICAL COMPOSITION FOR MODIFIED RELEASE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A08%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MURAYAMA,%20Emiko&rft.date=2021-05-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHUE052874TT2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |